Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Song Ling Poon

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Genome Medicine|May 28, 2015
Mutation signatures implicate aristolochic acid in bladder cancer developmentSong Ling Poon, Mi Ni Huang, Yang Choo, et al.
Anticancer Research|December 6, 2015
Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2Victoria Perrier-Trudova, Bernice Wong Huimin, Sarinya Kongpetch, et al.
Cancer Discovery|June 19, 2012
Janus kinase 3-activating mutations identified in natural killer/T-cell lymphomaGhee Chong Koo, Soo Yong Tan, Tiffany Tang, et al.
Nature Genetics|April 10, 2012
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genesZhi Jiang Zang, Ioana Cutcutache, Song Ling Poon, et al.
Science Translational Medicine|February 24, 2017
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2Lian Dee Ler, Sujoy Ghosh, Xiaoran Chai, et al.
Science Translational Medicine|August 9, 2013
Genome-wide mutational signatures of aristolochic acid and its application as a screening toolSong Ling Poon, See-Tong Pang, John R McPherson, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Genome Medicine|May 28, 2015
Mutation signatures implicate aristolochic acid in bladder cancer developmentSong Ling Poon, Mi Ni Huang, Yang Choo, et al.
Anticancer Research|December 6, 2015
Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2Victoria Perrier-Trudova, Bernice Wong Huimin, Sarinya Kongpetch, et al.
Cancer Discovery|June 19, 2012
Janus kinase 3-activating mutations identified in natural killer/T-cell lymphomaGhee Chong Koo, Soo Yong Tan, Tiffany Tang, et al.
Nature Genetics|April 10, 2012
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genesZhi Jiang Zang, Ioana Cutcutache, Song Ling Poon, et al.
Science Translational Medicine|February 24, 2017
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2Lian Dee Ler, Sujoy Ghosh, Xiaoran Chai, et al.
Science Translational Medicine|August 9, 2013
Genome-wide mutational signatures of aristolochic acid and its application as a screening toolSong Ling Poon, See-Tong Pang, John R McPherson, et al.
Pageof 3